Efficacy and safety analysis of lorlatinib for ALK-positive advanced NSCLC: a multicentre real-world study in China

ABSTRACT:

SUBMITTER: Chen Z 

PROVIDER: S-EPMC12297577 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature